UVEITIS
Clinical trials for UVEITIS explained in plain language.
Never miss a new study
Get alerted when new UVEITIS trials appear
Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Head-to-Head drug battle aims to save sight in stubborn eye disease
Disease control CompletedThis study tested three biologic drugs (adalimumab, anakinra, and tocilizumab) against each other in 112 people with non-infectious uveitis that did not improve with standard treatments. The goal was to see which drug best controls eye inflammation and reduces the need for steroi…
Matched conditions: UVEITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New imaging study tracks eye Implant's impact on uveitis
Knowledge-focused CompletedThis study followed 30 people with uveitis, an eye inflammation condition, who received a fluocinolone acetonide implant. Researchers used special eye scans to measure inflammation changes over 12 months. The goal was to see how well imaging can track treatment effects, not to te…
Matched conditions: UVEITIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:08 UTC
-
Eye disease biobank seeks clues to uveitis
Knowledge-focused CompletedThis study collected blood, saliva, and eye fluid samples from 343 people with uveitis, an inflammatory eye disease that can cause vision loss. Researchers aimed to learn which genes and other factors might lead to the disease and affect treatment response. Participants were foll…
Matched conditions: UVEITIS
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC